| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.3 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |